Диссертация (1174326), страница 24
Текст из файла (страница 24)
– P. 1021-1028.118. Hernandez-Diaz S., Toh S., Cnattingius S. Risk of pre-eclampsia in first andsubsequent pregnancies: prospective cohort study // Br Med J. – 2009. – 338. - P. 2255.119. Hitschold T.P. Doppler flow velocity waveforms of the umbilical arteries correlatewith intravillous blood volume // Am J Obstet Gynecol. – 1998. -179(2). – P. 540-543.120. Hoeben A., Landuyt B., Highley M.
Vascular endothelial growth factor andangiogenesis // Pharmacol Rev. – 2004. - 56. – P. 549–580.121. Jackson M.R., Walsh A.J., Morrow R.J., Mullen J.B., Lye S.J., Ritchie JW. Reducedplacental villous tree elaboration in small-for-gestational-age pregnancies: relationshipwith umbilical artery Doppler waveforms // Am J Obstet Gynecol. - 1995. - 172(2). – P.518-25.147122.
Jacobs M., Nassar N., Roberts C.L. Levels of soluble fms-like tyrosine kinase onein first trimester and outcomes of pregnancy: a systematic review // Reprod BiolEndocrinol. - 2011. – 9. – P. 77.123. James M. Roberts MD. Pathophysiology of ischemic placental disease // SeminPerinatol. – 2014. - 38(3). – P.
139–145.124. Johann S., Zoller C., Haas S., Blümel G., Lipp M., Förster R. Sulfatedpolysaccharide anticoagulants suppress natural killer cell activity in vitro // ThrombHaemost. – 1995. - 74(4). – P. 998-1002.125. Keshavarzi F., Mohammad pour-Gharehbagh A., Shahrakipour M., Teimoori B.,Yazdi A., Yaghmaei M., Naroeei-Nejad M., Salimi S. The placental vascular endothelialgrowth factor polymorphisms and preeclampsia/preeclampsia severity // Clin ExpHypertens. – 2017.
– 30. – P. 1-6.126. Khan K.S., Wojdyla D., Say L., Gülmezoglu A.M., van Look PF. WHO analysis ofcauses of maternal death: a systematic review // The Lancet. – 2006. - 367(9516). – P.1066–1074.127. Khodzhaeva Z.S., Kogan Y.A., Shmakov R.G., Klimenchenko N.I., Akatyeva A.S.,Vavina O.V., Kholin A.M., Muminova K.T., Sukhikh G.T. Clinical and pathogeneticfeatures of early- and late-onset pre-eclampsia // J Matern Fetal Neonatal Med. – 2016. 29(18). – P. 2980-2986.128. Khong T.Y. Placental vascular development and neonatal outcome // Seminars inNeonatology. – 2004. - 9(4). – P.
255–263.129. Khong Т., De Wolf F., Robertson W., Brosens I. Inadequate maternal vascularresponse to placentation in pregnancies complicated by preeclampsia and small forgestational age infants // Brit. J. Obstet. Gynecol. – 1986. - 93 (10). – P. 1049-1051.130. Kingdom J., Huppertz B., Seaward G., Kaufmann P. Development of the placentalvillous tree and its consequences for fetal growth // Eur J Obstet Gynecol Reprod Biol.
–2000. – 92. - P. 35–43.131. Kingdom J.C.P., Kaufmann P. Oxygen and placental villous development: originsof fetal hypoxia // Placenta. – 1997. – 18. – P. 613–621.148132. Kinzler W.L., Prasad V., Ananth C.V. The effect of maternal thrombophilia onplacental abruption: Histologic correlates. New Jersey-Placental Abruption StudyInvestigators. J Matern Fetal Neonatal Med. – 2009. - 22 (3).
– P. 243-248.133. Klungsoyr K., Morken N.H., Irgens L., Vollset S.E., Skjaerven R. Secular trends inthe epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, riskfactors and perinatal survival // Paediatr Perinat Epidemiol. – 2012. - 26(3). – P. 190–198.134. Kovo M., Schreiber L., Bar J. Placental vascular pathology as a mechanism ofdisease in pregnancy complications // Thromb Res.
– 2013. – 131. - P. 18–21.135. Kumazaki K., Nakayama M., Suehara N., Wada Y. Expression of vascularendothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR inhuman placenta under pathologic conditions // Hum Pathol. – 2002. – 33. – P. 1069–1077.136.
Kusanovic J.P., Romero R., Chaiworapongsa T. A prospective cohort study of thevalue of maternal plasma concentrations of angiogenic and anti-angiogenic factors inearly pregnancy and midtrimester in the identification of patients destined to developpreeclampsia // J Matern Fetal Neonatal Med. - 2009. – 22. – P.
1021–1038.137. Kwiatkowski S., Kwiatkowska E., Rzepka R., Torbe A., Dolegowska B. Ischemicplacental syndrome--prediction and new disease monitoring // J Matern Fetal NeonatalMed. – 2016. - 29(12). – P. 2033-2039.138. Lash G., MacPherson A., Liu D., Smith D., Charnock-Jones S., Baker P. Abnormalfetal growth is not associated with altered chorionic villous expression of vascularendothelial growth factor mRNA // Mol Hum Reprod.
– 2001. – 7. – P. 1093–1098.139. Leitner Y. Neurodevelopmental outcome of children with intrauterine growthretardation: a longitudinal, 10-year prospective study // J Child Neurol. – 2007. – 22. – P.580–587.140. Levine R.J., Karumanchi S.A. Circulating angiogenic factors in preeclampsia // ClinObstet Gynec. – 2005. – 48. P. 372-386.141. Lyall F., Young A., Boswell F., Kingdom J.C., Greer I.A. Placental expression ofvascular endothelial growth factor in placentae from pregnancies complicated by pre-149eclampsia and intrauterine growth restriction does not support placental hypoxia atdelivery // Placenta. – 1997.
– 18. – P. 269–276.142. Lyall F. The Placenta in preeclampsia. The Placenta from development to disease //Wiley Blackwell. – 2011. – P. 246—252.143. Lykke, J.A., Bare, L.A., Olsen, J., Lagier, R., Arellano, A.R., Tong, C., Paidas, M.J.& Langhoff-Roos, J. Thrombophilias and adverse pregnancy outcomes: results from theDanish National Birth Cohort // J. Thromb. Haemost. - 2012. – 10 (7). – P. 1320-1325.144. Macara L., Kingdom J.C., Kaufmann P., Kohnen G., Hair J., More I.A.
Structuralanalysis of placental terminal villi from growth-restricted pregnancies withabnormalumbilical artery Doppler waveforms // Placenta. – 1996. -17(1). – P. 37-48.145. Marcorelles P. Placental features in intrauterine growth retardation // J GynecolObstet Biol Reprod (Paris). – 2013. – 42. – P.
996–1007.146. Marek Z., Friederike P.L., Karsten M., Lang U., Liang O. Angiogenesis andvasculogenesis in pregnancy // Europ. J. of Obstet. & Gynecol. & Re-produc. Biol. –2003. – 110. – P. 10-15.147. Martinelli, I., Ruggenenti, P., Cetin, I., Pardi, G., Perna, A., Vergani, P. Heparin inpregnant women with previous placenta-mediated pregnancy complications: aprospective, randomized, multicenter, controlled clinical trial // Blood. – 2012. – 119.
–P. 3269–3275.148. Mayhew T.M., Charnock-Jones D.S., Kaufmann P. Aspects of human fetoplacentalvasculogenesis and angiogenesis. Part Ш. Changes in Complicated Pregnancies //Placenta. – 2004. – 25. - P. 127-139.149. Mayhew T.M., Ohadike C., Baker P.N., Crocker I.P., Mitchell C., Ong S.S.Stereological investigation of placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction // Placenta. – 2003.
- 24(2-3).- P. 219–226.150. Mayhew T.M., Wijesekara J., Baker P.N, Ong S.S. Morphometric evidence thatvillous development and fetoplacental angiogenesis are compromised by intrauterinegrowth restriction but not by pre-eclampsia // Placenta. - 2004. - 25(10). – P. 829–833.150151. Mayhew T.M. Changes in fetal capillaries during preplacental hypoxia: growth,shape remodelling and villous capillarization in placentas from high-altitude pregnancies// Placenta.
– 2003. – 24. – P. 191–198.152. Mayhew T.M. Patterns of villous and intervillous space growth in human placentasfrom normal and abnormal pregnancies // European Journal of Obstetrics Gynecologyand Reproductive Biology. – 1996. - 68(1-2). – P. 75–82.153. Maynard S.E., Min J.Y., Merchan J. Excess placental soluble fms-like tyrosinekinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuriain preeclampsia // J Clin Invest. – 2003. – 111.
- P. 649-658.154. McLaughlin K., Baczyk D., Potts A, Hladunewich M., Parker J.D., Kingdom J.C.Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women atHigh Risk of Preeclampsia // Hypertension. – 2017. - 69(1). – P. 180-188.155.
Melamed N., Hadar E., Peled Y., Hod M., Wiznitzer A., Yogev Y. Risk forrecurrence of preeclampsia and outcome of subsequent pregnancy in women withpreeclampsia in their first pregnancy // J Matern Fetal Neonatal Med. – 2012. - 25(11). –P. 2248–2251.156. Mello G., Parretti E., Fatini C., Riviello C., Gensini F., Marchionni M., ScarselliG.F., Gensini G.F. & Abbate, R. Low-molecular-weight heparin lowers the recurrencerate of preeclampsia and restores the physiological vascular changes in angiotensinconverting enzyme DD women // Hypertension.
– 2005. – 45. – P. 86–91.157. Mello G., Parretti E., Marozio L., Pizzi C., Lojacono A., Frusca T., Facchinetti F.,Benedetto C. Thrombophilia is significantly associated with severe preeclampsia: resultsof a large-scale, case-controlled study // Hypertension. – 2005. - 46(6). – P. 1270-1274.158. Mitra S.C., Seshan S.V., Riachi L.E. Placental vessel morphometry in growthretardation and increased resistance of the umbilical artery Doppler flow // J Matern FetalNeonatal Med. – 2000. – 9. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
